1842 related articles for article (PubMed ID: 18721733)
1. Vitamin D deficiency and associated factors in hemodialysis patients.
Jean G; Charra B; Chazot C
J Ren Nutr; 2008 Sep; 18(5):395-9. PubMed ID: 18721733
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of 25(OH) vitamin D insufficiency and deficiency in chronic kidney disease stage 5 patients on hemodialysis.
Del Valle E; Negri AL; Aguirre C; Fradinger E; Zanchetta JR
Hemodial Int; 2007 Jul; 11(3):315-21. PubMed ID: 17576296
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of vitamin D [25(OH)D] deficiency and effects of supplementation with ergocalciferol (vitamin D2) in stage 5 chronic kidney disease patients.
Blair D; Byham-Gray L; Lewis E; McCaffrey S
J Ren Nutr; 2008 Jul; 18(4):375-82. PubMed ID: 18558303
[TBL] [Abstract][Full Text] [Related]
4. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2008 Nov; 23(11):3670-6. PubMed ID: 18579534
[TBL] [Abstract][Full Text] [Related]
5. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
6. Monthly cholecalciferol administration in haemodialysis patients: a simple and efficient strategy for vitamin D supplementation.
Jean G; Souberbielle JC; Chazot C
Nephrol Dial Transplant; 2009 Dec; 24(12):3799-805. PubMed ID: 19622574
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D status of chronic kidney disease patients living in a sunny country.
Cuppari L; Carvalho AB; Draibe SA
J Ren Nutr; 2008 Sep; 18(5):408-14. PubMed ID: 18721735
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London.
Moniz C; Dew T; Dixon T
Curr Med Res Opin; 2005 Dec; 21(12):1891-4. PubMed ID: 16368037
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D insufficiency in a population of healthy western Canadians.
Rucker D; Allan JA; Fick GH; Hanley DA
CMAJ; 2002 Jun; 166(12):1517-24. PubMed ID: 12074117
[TBL] [Abstract][Full Text] [Related]
11. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of vitamin D inadequacy in Belfast following fragility fracture.
Beringer T; Heyburn G; Finch M; McNally C; McQuilken M; Duncan M; Dixon T
Curr Med Res Opin; 2006 Jan; 22(1):101-5. PubMed ID: 16393436
[TBL] [Abstract][Full Text] [Related]
13. [Hypertension in hemodialysis patients in Andalucia].
García Cortés MJ; Ceballos M;
Nefrologia; 2004; 24(2):149-57. PubMed ID: 15219090
[TBL] [Abstract][Full Text] [Related]
14. Vitamin D deficiency in healthy children in a sunny country: associated factors.
Bener A; Al-Ali M; Hoffmann GF
Int J Food Sci Nutr; 2009; 60 Suppl 5():60-70. PubMed ID: 18946796
[TBL] [Abstract][Full Text] [Related]
15. Evidence for persistent vitamin D 1-alpha-hydroxylation in hemodialysis patients: evolution of serum 1,25-dihydroxycholecalciferol after 6 months of 25-hydroxycholecalciferol treatment.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephron Clin Pract; 2008; 110(1):c58-65. PubMed ID: 18724068
[TBL] [Abstract][Full Text] [Related]
16. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients.
Tokmak F; Quack I; Schieren G; Sellin L; Rattensperger D; Holland-Letz T; Weiner SM; Rump LC
Nephrol Dial Transplant; 2008 Dec; 23(12):4016-20. PubMed ID: 18593741
[TBL] [Abstract][Full Text] [Related]
17. The impact of routine vitamin supplementation on serum levels of 25 (OH) D3 among the general adult population and patients with chronic kidney disease.
Tareen N; Martins D; Zadshir A; Pan D; Norris KC
Ethn Dis; 2005; 15(4 Suppl 5):S5-102-6. PubMed ID: 16315388
[TBL] [Abstract][Full Text] [Related]
18. [Review of the concept of vitamin D "sufficiency and insufficiency"].
Gómez Alonso C; Naves Díaz M; Rodríguez García M; Fernández Martín JL; Cannata Andía JB
Nefrologia; 2003; 23 Suppl 2():73-7. PubMed ID: 12778859
[TBL] [Abstract][Full Text] [Related]
19. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
Dong J; Wang H; Wang M
J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
[TBL] [Abstract][Full Text] [Related]
20. Improvement of bone and mineral parameters related to adynamic bone disease by diminishing dialysate calcium.
Spasovski G; Gelev S; Masin-Spasovska J; Selim G; Sikole A; Vanholder R
Bone; 2007 Oct; 41(4):698-703. PubMed ID: 17643363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
